The first two weeks of 2021 have been quiet on the US FDA drug approval front, but the annual (albeit virtual) J.P. Morgan conference once again ensured a steady flow of sponsor news.
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker
